Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
Clinical trial NCT06855095 · RECRUITING
Trial details
- NCT number
- NCT06855095
- Sponsor
- The Netherlands Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2027-01-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.